Two Sigma Advisers’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-322,300
Closed -$5.69M 1790
2025
Q4
$5.69M Buy
+322,300
New +$5.33M 0.01% 748
2024
Q3
Sell
-15,200
Closed -$180K 2499
2024
Q2
$180K Sell
15,200
-36,700
-71% -$419K ﹤0.01% 2237
2024
Q1
$623K Buy
51,900
+3,800
+8% +$56.6K ﹤0.01% 1774
2023
Q4
$810K Sell
48,100
-11,600
-19% -$164K ﹤0.01% 1730
2023
Q3
$894K Sell
59,700
-13,400
-18% -$226K ﹤0.01% 1569
2023
Q2
$1.38M Sell
73,100
-9,800
-12% -$156K ﹤0.01% 1398
2023
Q1
$1.48M Sell
82,900
-55,680
-40% -$930K ﹤0.01% 1433
2022
Q4
$1.15M Sell
138,580
-126,620
-48% -$945K ﹤0.01% 1510
2022
Q3
$1.81M Buy
265,200
+225,300
+565% +$3.75M 0.01% 1221
2022
Q2
$782K Buy
39,900
+3,400
+9% +$71.2K ﹤0.01% 1714
2022
Q1
$791K Buy
36,500
+13,600
+59% +$288K ﹤0.01% 1770
2021
Q4
$539K Sell
22,900
-1,200
-5% -$28.7K ﹤0.01% 1879
2021
Q3
$630K Buy
+24,100
New +$583K ﹤0.01% 1828
2021
Q2
Sell
-33,200
Closed -$829K 2668
2021
Q1
$829K Sell
33,200
-31,000
-48% -$820K ﹤0.01% 1749
2020
Q4
$1.76M Buy
+64,200
New +$1.72M ﹤0.01% 1323

Other funds holding SHC

Two Sigma Advisers's SHC Position: Q1 2026 in Review

Two Sigma Advisers sold out of Sotera Health (SHC) in Q1 2026, closing a stake of 322,300 shares — an estimated $5.69M sold.

Two Sigma Advisers first reported a position in SHC in Q4 2020 and held it in 15 quarters. The position peaked at $5.69M in Q4 2025. 299 funds tracked by Wall St. Rank hold SHC as of Q1 2026.

  • Two Sigma Advisers reported no remaining Sotera Health position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 322,300 Sotera Health shares in Q1 2026, an estimated $5.69M.
  • Two Sigma Advisers first reported a position in Sotera Health in Q4 2020 and held it in 15 quarters.
  • Two Sigma Advisers's Sotera Health position peaked at $5.69M in Q4 2025.
  • 299 funds tracked by Wall St. Rank held Sotera Health as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.